Login to Your Account



Fusion energized in targeted radiotherapy effort with $25M series A

By Marie Powers
News Editor

Thursday, February 23, 2017

After several years incubating in the Centre for Probe Development and Commercialization at McMaster University in Hamilton, Ontario, Fusion Pharmaceuticals Inc. is hanging out its shingle.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription